Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Cyclophosphamide 150mg	14
Overall Study	STARTED	Cyclophosphamide 100mg	41
Overall Study	STARTED	Cyclophosphamide 50mg	39
Overall Study	STARTED	Fludarabine	3
Overall Study	Phase I	Cyclophosphamide 150mg	6
Overall Study	Phase I	Cyclophosphamide 100mg	6
Overall Study	Phase I	Cyclophosphamide 50mg	6
Overall Study	Phase I	Fludarabine	3
Overall Study	Phase II	Cyclophosphamide 150mg	8
Overall Study	Phase II	Cyclophosphamide 100mg	35
Overall Study	Phase II	Cyclophosphamide 50mg	33
Overall Study	Phase II	Fludarabine	0
Overall Study	COMPLETED	Cyclophosphamide 150mg	0
Overall Study	COMPLETED	Cyclophosphamide 100mg	41
Overall Study	COMPLETED	Cyclophosphamide 50mg	38
Overall Study	COMPLETED	Fludarabine	0
Overall Study	NOT COMPLETED	Cyclophosphamide 150mg	14
Overall Study	NOT COMPLETED	Cyclophosphamide 100mg	0
Overall Study	NOT COMPLETED	Cyclophosphamide 50mg	1
Overall Study	NOT COMPLETED	Fludarabine	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00326417/flow